MSI-H/dMMR Gastric Cancer
3 clinical trials · Condition
◉ Watch MSI-H/dMMR Gastric Cancer
| Record | Firm | Date |
|---|---|---|
| EIK1005-002: A Clinical Research Study Evaluating EIK1005, a Werner Helicase Inhibitor, as Monotherapy and in Combination With Pembrolizumab in Participants With Advanced Solid Tumors Including Microsatellite Instability High (MSI-H) Tumors (NCT07262619) | Eikon Therapeutics | 2026-01-20 |
| Zimberelimab Anti-PD1 +/- Domvanalimab in Resectable Mmrd Gastric Cancer (NCT06250036) | Royal Marsden NHS Foundation Trust | 2025-02-20 |
| A Study to Evaluate the Safety and the Activity of S095029 as Part of Combination Therapy in Advanced Gastroesophageal Junction/Gastric Cancers. (NCT06116136) | Servier Bio-Innovation LLC | 2024-08-31 |
Track MSI-H/dMMR Gastric Cancer automatically
Every clearance here is in the API, with alerts when new ones post.